Dyslipidemia correction by polychemotherapy treatment in patients with Hodgkin lymphoma and non-Hodgkin malignant lymphomas
The disorders of lipid metabolism in patients with Hodgkin’s lymphoma and non-Hodgkin’s malignant lymphomas appeared during the course of anticancer therapy have been investigated. The significant increase in cholesterol and triglyceride serum levels has been revealed in patients in the dynamics of chemotherapy courses. The safe and effective correction of secondary dyslipidemia in patients with neoplastic blood diseases with the use of natural zeolites has been proposed.
About Authors (Correspondence):
Chernysheva A.S. – candidate of medical sciences, е-mail: firstname.lastname@example.org
Panin L.E. – academician of RAMS, doctor of medical sciences
Tuzikov F.V. – doctor of biological sciences, е-mail: email@example.com
Tuzikova N.A. – е-mail: firstname.lastname@example.org